On Air Now

Tune in to Listen

99.9 FM Hibbing, MN

Weather

Current Conditions(Hibbing,MN 55746)

More Weather »
42° Feels Like: 38°
Wind: SSE 7 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

AM Clouds/PM Sun 62°

Tonight

Partly Cloudy 49°

Tomorrow

Scattered Thunderstorms 65°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

Roche says Gazyvaro approved in Europe against leukemia

ZURICH (Reuters) - Roche said on Tuesday that European regulators approved its drug Gazyvaro, or obinutuzumab, for patients with chronic lymphocytic leukemia, boosting the Swiss group's line-up of new cancer treatments.

The new medicine is an improved follow-on medicine to the Swiss drugmaker's $7 billion-a-year Rituxan, or MabThera, and Roche is hoping to switch as many patients as possible to the newer product before Rituxan faces competition from cheaper copies.

The move endorses a favorable recommendation in May from the European Medicine Agency's Committee for Medicinal Products for Human Use (CHMP), which are normally followed by the European Commission.

(Reporting By Katharina Bart)

Comments